Understanding Transglutaminase 2 and Its Role in Celiac Disease
Author Information
Author(s): Frits Koning
Primary Institution: Leiden University Medical Center
Hypothesis
What regulates the activation of transglutaminase 2 and how does it influence disease development?
Conclusion
The study reveals a novel structure of transglutaminase 2 in its active form, which may aid in developing specific inhibitors for diseases like celiac disease.
Supporting Evidence
- Transglutaminase 2 modifies gluten peptides, allowing them to bind to immune receptors.
- The study provides insights into the mechanism of TG2 activation and its implications for celiac disease.
- Understanding TG2's structure may lead to the development of therapeutic inhibitors.
Takeaway
Transglutaminase 2 is an enzyme that helps in processing gluten, and understanding how it works can help in treating celiac disease.
Methodology
The structure of the active form of transglutaminase 2 was captured in complex with an inhibitor derived from gluten.
Limitations
The study does not clarify why TG2 activation occurs only in celiac disease patients and not in healthy individuals.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website